Department
Natural Sciences and Mathematics
Document Type
Article
Source
The Journal of Experimental Medicine
Publication Date
12-6-2021
ISSN
1540-9538
Volume
218
Issue
12
Abstract
Innovative drug treatments for malaria, optimally with novel targets, are needed to combat the threat of parasite drug resistance. As drug development efforts continue, there may be a role for a host-targeting, repurposed cancer drug administered together with an artemisinin combination therapy that was shown to improve the speed of recovery from a malaria infection.
PubMed ID
34807244
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.